A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target

23Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

Abstract

Nowadays, the emergence of multidrug-resistant bacterial strains initiates the urgent need for the elucidation of the new drug targets for the discovery of antimicrobial drugs. Filamenting temperature-sensitive mutant Z (FtsZ), a eukaryotic tubulin homolog, is a GTP-dependent pro-karyotic cytoskeletal protein and is conserved among most bacterial strains. In vitro studies revealed that FtsZ self-assembles into dynamic pro-tofilaments or bundles and forms a dynamic Z-ring at the center of the cell in vivo, leading to septation and consequent cell division. Speculations on the ability of FtsZ in the blockage of cell division make FtsZ a highly attractive target for developing novel antibiotics. Researchers have been working on synthetic molecules and natural products as inhibitors of FtsZ. Accumulating data suggest that FtsZ may provide the platform for the development of novel antibiotics. In this review, we summarize recent advances in the properties of FtsZ protein and bacterial cell division, as well as in the development of FtsZ inhibitors.

Cite

CITATION STYLE

APA

Rahman, M. U., Wang, P., Wang, N., & Chen, Y. (2020). A key bacterial cytoskeletal cell division protein FtsZ as a novel therapeutic antibacterial drug target. Bosnian Journal of Basic Medical Sciences. Association of Basic Medical Sciences of FBIH. https://doi.org/10.17305/bjbms.2020.4597

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free